Neuromuscular paraneoplastic syndromes: The Lambert-Eaton myasthenic syndrome

Journal of Palliative Medicine

Volumn 13, Issue 9, 2010, Pages 1159-1162

  Prommer, Eric ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 DIAMINOPYRIDINE; ANTINEOPLASTIC AGENT; PREDNISONE;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; BRONCHOSCOPY; CANCER CHEMOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; EATON LAMBERT SYNDROME; FEMALE; HUMAN; LUNG SMALL CELL CANCER; MUSCLE STRENGTH; MUSCLE WEAKNESS; NEUROMUSCULAR SYNAPSE; PARANEOPLASTIC NEUROPATHY; PATHOPHYSIOLOGY; PNEUMONIA; THORAX RADIOGRAPHY;

DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; FEMALE; HUMANS; LAMBERT-EATON MYASTHENIC SYNDROME; MIDDLE AGED;

EID: 77956587193     PISSN: 10966218     EISSN: None     Source Type: Journal    
DOI: 10.1089/jpm.2009.0418     Document Type: Article

References (29)

1. Darnell RB, Posner JB: Paraneoplastic syndromes involving the nervous system. N Engl J Med 2003;349:1543-1554.
2. Seneviratne U, de Silva R: Lambert-Eaton myasthenic syndrome. Postgrad Med J 1999;75:516-520.
3. Wirtz PW, Lang B, Graus F, van den Maagdenberg AM, Saiz A, de Koning Gans PA, Twijnstra A, Verschuuren JJ: P/Q-type calcium channel antibodies, Lambert-Eaton myasthenic syndrome and survival in small cell lung cancer. J Neu-roimmunol 2005;164:161-165. (Pubitemid 40826775)
4. Wirtz PW, Smallegange TM, Wintzen AR, Verschuuren JJ: Differences in clinical features between the Lambert-Eaton myasthenic syndrome with and without cancer: An analysis of 227 published cases. Clin Neurol Neurosurg 2002;104: 359-363.
5. Mareska M, Gutman L: Lambert-Eaton myasthenic syndrome. Seminars in Neurology 2004;24:149.
6. Boonyapisit K, Kaminski HJ, Ruff RL: Disorders of neuro-muscular junction ion channels. Am J Med 1999;106:97-113.
7. Oh SJ, Kurokawa K, Claussen GC, Ryan JR: Electro-physiological diagnostic criteria of Lambert-Eaton myas-thenic syndrome. Muscle Nerve 2005;32:515-520.
8. Benatar M, Blaes F, Johnston I,Wilson K, Vincent A, Beeson D, Lang B: Presynaptic neuronal antigens expressed by a small cell lung carcinoma cell line. J Neuroimmunol 2001; 113:153-162.
9. Lennon VA, Kryzer TJ, Griesmann GE O'Suilleabhain PE, Windebank AJ, Woppmann A, Miljanich GP, Lambert EH: Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med 1995; 332:1467-1475.
10. Seneviratne U, de Silva R: Classic diseases revisited: Lambert-Eaton myasthenic syndrome. Postgrad Med J 1999;75: 516-520.
11. Titulaer MJ, Klooster R, Potman M, Sabater L, Graus F, Hegeman IM, Thijssen PE, Wirtz PW, Twijnstra A, Smitt PA, van der Maarel SM, Verschuuren JJ: SOX antibodies in small-cell lung cancer and Lambert-Eaton myasthenic syndrome: Frequency and relation with survival. J Clin Oncol 2009;27:4260-4267.
12. O'Neill JH, Murray NMF, Newsom-Davis J: The Lambert-Eaton Myasthenic syndrome: A review of 50 cases. Brain 1988;111:577-596.
13. Wirtz PW, Sotodeh M, Nijnuis M,Van Doorn PA, Van Engelen BG, Hintzen RQ, De Kort PL, Kuks JB, Twijnstra A, De Visser M, Visser LH, Wokke JH, Wintzen AR, Ver-schuuren JJ: Difference in distribution of muscle weakness between myasthenia gravis and the Lambert-Eaton myas-thenic syndrome. J Neurol Neurosurg Psychiatry 2002;73: 766-768.
14. Chalk CH, Murray NMF, Newsom-Davis J, O'Neill JH, Spiro SG: Response of the Lambert-Eaton myasthenic syndrome to treatment of associated small-cell lung carcinoma. Neurology 1990;40:1552-1556.
15. Alexopoulou A, Dourakis SP, Louka O, Marinaki O, Kal-mantis T: Hairy cell leukemia and Lambert-Eaton myas-thenic syndrome. Leukemia 2003;17:655-656.
16. De Buys Roessingh AS, Loriot MH, Wiesenauer C, Lallier M: Lambert-Eaton myasthenic syndrome revealing an abdominal neuroblastoma. J Pediatr Surg 2009;44:e5-e7.
17. Jost WH, Mielke U, Forrett-Kaminsky MC, Schimrigk K: Long-term treatment of Lambert-Eaton syndrome by 3, 4 diaminopyridine. Revue neurologique 1992;148:776.
18. Oh SJ, Kim DS, Head TC, Claussen GC: Low-dose guanidine and pyridostigmine: Relatively safe and effective long-term symptomatic therapy in Lambert-Eaton myasthenic syndrome. Muscle Nerve 1997 Sep;20(9):1146-1152.
19. Wirtz PW, Verschuuren JJ, van Dijk JG, de Kam ML, Schoemaker RC, van Hasselt JG, Titulaer MJ, Tjaden UR, den Hartigh J, van Gerven JM. et al. Efficacy of 3,4-diaminopyridine and pyridostigmine in the treatment of Lambert-Eaton Myasthenic syndrome: A randomized, double-blind, placebo-controlled, crossover study. Clin Pharmacol Ther 2009;86:44-48.
20. Newsome-Davis J: Therapy in Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome. Seminars in Neurology 2003;23:191-198.
21. Bain PG, Motomura M, Newsom-Davis J, Misbah SA, Chapel HM, Lee ML, Vincent A, Lang B: Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome. Neurology 1996;47:678-683.
22. Newsom-Davis J, Murray NM: Plasma exchange and im-munosuppressive drug treatment in the Lambert-Eaton myasthenic syndrome. Neurology 1984;34:480.
23. Perez Paredes MG, Martin Escudero JC, Perez Castrillon JL, Herreros FV: [Extreme weakness associated with gastric adenocarcinoma: Beyond the expected]. Rev Clin Esp 2003;203:157-158.
24. Argov Z, Shapira Y, Averbuch-Heller L, Wirguin I: Lambert-Eaton myasthenic syndrome (LEMS) in association with lymphoproliferative disorders. Muscle Nerve 1995;18:715-719.
25. Delahunt B, Abernethy DA, Johnson CA, Nacey JN: Prostate carcinoma and the Lambert-Eaton Myasthenic syndrome. J Urol 2003;169:278-279.
26. Lee JH, Shin JH, Kim DS, Jung DS, Park KH, Lee MK, Kim JY: A case of Lambert-Eaton Myasthenic syndrome associated with atypical bronchopulmonary carcinoid tumor. J Korean Med Sci 2004;19:753-755.
27. Eggers SD, Salomao DR, Dinapoli RP, Vernino S: Para-neoplastic and metastatic neurologic complications of Mer-kel cell carcinoma. Mayo Clin Proc 2001;76:327-330.
28. Zivaljevic M, Popovic S, Vujkov T: [Lambert-Eaton myas-thenic syndrome\A rare manifestation of paraneoplastic syndrome in ovarian cancer\Case report]. Med Pregl 2005; 58:495-497.
29. Shipley E, Krim E, Deminiere C, Lagueny A: [Lambert-Eaton Myasthenic Syndrome associated with vocal cord carcinoma]. Rev Neurol (Paris) 2008;164:72-76.